Voltammetric Behavior of Antileukemia Dr
✍
Victor Constantin Diculescu; Marilene Vivan; Ana Maria Oliveira Brett
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
English
⚖ 126 KB
## Abstract Glivec is a newly developed drug that belongs to the class of 2‐phenylaminopyrimidine. It is a potent inhibitor of __ABL__‐kinase, the main clinical manifestation of chronic myelogenous leukemia (CML). Based on its activity on CML, glivec is undergoing extensive evaluation for its activ